These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4375921)

  • 21. Ultrastructure of the cell wall of Escherichia coli and chemical nature of its constituent layers.
    De Petris S
    J Ultrastruct Res; 1967 Jul; 19(1):45-83. PubMed ID: 4961452
    [No Abstract]   [Full Text] [Related]  

  • 22. The antibacterial effect of Bordetella pertussis antisera.
    Dolby JM
    Immunology; 1965 May; 8(5):484-98. PubMed ID: 4284285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attempts at isolation of lymphocytosis-producing factor from supernatant fluids of Bordetella pertussis cultures.
    Okuyama S; Aronson RB; Chanana AD; Cronkite EP; Rai KR; Schiffer LM
    Proc Soc Exp Biol Med; 1970 Feb; 133(2):723-7. PubMed ID: 4313155
    [No Abstract]   [Full Text] [Related]  

  • 24. Identification of 2-methyl-3-hydroxydecanoic and 2-methyl-3-hydroxytetradecanoic acids in the 'lipid X' fraction of the Bordetella pertussis endotoxin.
    Haeffner N; Chaby R; Szabó L
    Eur J Biochem; 1977 Aug; 77(3):535-44. PubMed ID: 196857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Partial purification and some properties of the leukocytosis-promoting material from Bordetella pertussis.
    Sato Y; Arai H
    Jpn J Med Sci Biol; 1970 Aug; 23(4):273-6. PubMed ID: 4099421
    [No Abstract]   [Full Text] [Related]  

  • 26. [Bordetella pertussis spheroplasts. 2. The protective action of spheroplasts and spheroplast fractions].
    Milleck J; Ocklitz HW
    Zentralbl Bakteriol Orig A; 1972 Jan; 219(1):85-92. PubMed ID: 4402416
    [No Abstract]   [Full Text] [Related]  

  • 27. Lymphocytosis-promoting factor produced by Bordetella pertussis. Partial purification and characterization.
    Uiwasa S; Ishida S; Asakawa S; Kurokawa M
    Jpn J Med Sci Biol; 1968 Oct; 21(5):363-8. PubMed ID: 4304392
    [No Abstract]   [Full Text] [Related]  

  • 28. Electron microscopic localization of endotoxic lipopolysaccharide in gram-negative organisms.
    Mergenhagen SE; Bladen HA; Hsu KC
    Ann N Y Acad Sci; 1966 Jun; 133(2):279-91. PubMed ID: 4960343
    [No Abstract]   [Full Text] [Related]  

  • 29. Antigens of Bordetella pertussis. I. Activities of cell walls and protoplasm.
    MUNOZ J; RIBI E; LARSON CL
    J Immunol; 1959 Nov; 83():496-501. PubMed ID: 14425265
    [No Abstract]   [Full Text] [Related]  

  • 30. [A study of toxic substances in pertussis cultures].
    Malivanova OM
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Nov; (11):93-7. PubMed ID: 188276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of cyclodextrin as an agent to induce excretion of Bordetella pertussis antigens.
    Hozbor D; Rodriguez ME; Yantorno O
    FEMS Immunol Med Microbiol; 1994 Aug; 9(2):117-24. PubMed ID: 7804162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heat-labile toxin of Bordetella pertussis purified by preparative acrylamide gel electrophoresis.
    Nakase Y; Takatsu K; Tateishi M; Sekiya K; Kasuga T
    Jpn J Microbiol; 1969 Dec; 13(4):359-66. PubMed ID: 4311586
    [No Abstract]   [Full Text] [Related]  

  • 33. [Relations between the chemical composition, antigenic activity and toxicity of chemical fractions extracted from species of the genus Bordetella].
    Sefer M; Fessler N; Butu-Constantinesco R; Petcou MR
    Arch Roum Pathol Exp Microbiol; 1966 Jun; 25(2):441-50. PubMed ID: 5985365
    [No Abstract]   [Full Text] [Related]  

  • 34. Radiolabelling of Bordetella pertussis envelope proteins by the 125 I-lactoperoxidase method.
    Gow JA; Parton R; Wardlaw AC
    Microbios; 1976; 15(61-62):209-19. PubMed ID: 189162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of ifferent bactericidal systems on B. prtussis and B. parapertussis organisms.
    Pusztai Z; Csizér Z; Joó I
    Z Immunitatsforsch Allerg Klin Immunol; 1970; 141(1):1-13. PubMed ID: 4322354
    [No Abstract]   [Full Text] [Related]  

  • 36. Cell envelopes of gram negative bacteria: composition, response to chelating agents and susceptibility of whole cells to antibacterial agents.
    Haque H; Russell AD
    J Appl Bacteriol; 1976 Feb; 40(1):89-99. PubMed ID: 818069
    [No Abstract]   [Full Text] [Related]  

  • 37. Changes in morphology and cell wall structure that occur during growth of Vibrio sp. NCTC4716 in batch culture.
    Baker DA; Park RW
    J Gen Microbiol; 1975 Jan; 86(1):12-28. PubMed ID: 803546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The protective action of cell walls and cytoplasm of Bordetella pertussis].
    Milleck J
    Z Immunitatsforsch Allerg Klin Immunol; 1967 Jul; 133(2):126-33. PubMed ID: 4298314
    [No Abstract]   [Full Text] [Related]  

  • 39. Phenotypic expression of an envC-division mutant of Escherichia coli K12.
    Starka J; Di Savino D; Michel G; Rodolakis A; Thomas P
    Ann Microbiol (Paris); 1974 Sep; 125 B(2):227-32. PubMed ID: 4218460
    [No Abstract]   [Full Text] [Related]  

  • 40. Characterization of a protein-lipopolysaccharide complex released from cell walls of Pseudomonas aeruginosa by ethylenediaminetetraacetic acid.
    Rogers SW; Gilleland HE; Eagon RG
    Can J Microbiol; 1969 Jul; 15(7):743-8. PubMed ID: 4978710
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.